Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1998 Jun;57(6):325–327. doi: 10.1136/ard.57.6.325

Should we look for osteoporosis in patients with rheumatoid arthritis?

W LEMS 1, B DIJKMANS 1
PMCID: PMC1752623  PMID: 9771204

Full Text

The Full Text of this article is available as a PDF (93.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bijlsma J. W. Prevention of glucocorticoid induced osteoporosis. Ann Rheum Dis. 1997 Sep;56(9):507–509. doi: 10.1136/ard.56.9.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Black D. M., Cummings S. R., Karpf D. B., Cauley J. A., Thompson D. E., Nevitt M. C., Bauer D. C., Genant H. K., Haskell W. L., Marcus R. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996 Dec 7;348(9041):1535–1541. doi: 10.1016/s0140-6736(96)07088-2. [DOI] [PubMed] [Google Scholar]
  3. Cooper C., Coupland C., Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis. 1995 Jan;54(1):49–52. doi: 10.1136/ard.54.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cooper C., Kanis J. A., Compston J. How to assess drug efficacy in osteoporosis. Lancet. 1995 Mar 25;345(8952):743–744. doi: 10.1016/s0140-6736(95)90635-5. [DOI] [PubMed] [Google Scholar]
  5. Deodhar A. A., Woolf A. D. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol. 1996 Apr;35(4):309–322. doi: 10.1093/rheumatology/35.4.309. [DOI] [PubMed] [Google Scholar]
  6. Eastell R. Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis. J Intern Med. 1995 May;237(5):439–447. doi: 10.1111/j.1365-2796.1995.tb00868.x. [DOI] [PubMed] [Google Scholar]
  7. Eggelmeijer F., Camps J. A., Valkema R., Papapoulos S. E., Pauwels E. K., Dijkmans B. A., Breedveld F. C. Bone mineral density in ambulant, non-steroid treated female patients with rheumatoid arthritis. Clin Exp Rheumatol. 1993 Jul-Aug;11(4):381–385. [PubMed] [Google Scholar]
  8. Eggelmeijer F., Papapoulos S. E., Westedt M. L., Van Paassen H. C., Dijkmans B. A., Breedveld F. C. Bone metabolism in rheumatoid arthritis; relation to disease activity. Br J Rheumatol. 1993 May;32(5):387–391. doi: 10.1093/rheumatology/32.5.387. [DOI] [PubMed] [Google Scholar]
  9. Eggelmeijer F., Papapoulos S. E., van Paassen H. C., Dijkmans B. A., Valkema R., Westedt M. L., Landman J. O., Pauwels E. K., Breedveld F. C. Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial. Arthritis Rheum. 1996 Mar;39(3):396–402. doi: 10.1002/art.1780390307. [DOI] [PubMed] [Google Scholar]
  10. Garton M. J., Reid D. M. Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis. Effects of low-dose corticosteroids. Arthritis Rheum. 1993 Feb;36(2):222–228. doi: 10.1002/art.1780360213. [DOI] [PubMed] [Google Scholar]
  11. Gough A. K., Lilley J., Eyre S., Holder R. L., Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994 Jul 2;344(8914):23–27. doi: 10.1016/s0140-6736(94)91049-9. [DOI] [PubMed] [Google Scholar]
  12. Guidelines for osteoporosis trials. J Rheumatol. 1997 Jun;24(6):1234–1236. [PubMed] [Google Scholar]
  13. Hooyman J. R., Melton L. J., 3rd, Nelson A. M., O'Fallon W. M., Riggs B. L. Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum. 1984 Dec;27(12):1353–1361. doi: 10.1002/art.1780271205. [DOI] [PubMed] [Google Scholar]
  14. Joffe I., Epstein S. Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin Arthritis Rheum. 1991 Feb;20(4):256–272. doi: 10.1016/0049-0172(91)90021-q. [DOI] [PubMed] [Google Scholar]
  15. Kanis J. A., Delmas P., Burckhardt P., Cooper C., Torgerson D. Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int. 1997;7(4):390–406. doi: 10.1007/BF01623782. [DOI] [PubMed] [Google Scholar]
  16. Laan R. F., Buijs W. C., Verbeek A. L., Draad M. P., Corstens F. H., van de Putte L. B., van Riel P. L. Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis. 1993 Jan;52(1):21–26. doi: 10.1136/ard.52.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lems W. F., Gerrits M. I., Jacobs J. W., van Vugt R. M., van Rijn H. J., Bijlsma J. W. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 1996 May;55(5):288–293. doi: 10.1136/ard.55.5.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Liberman U. A., Weiss S. R., Bröll J., Minne H. W., Quan H., Bell N. H., Rodriguez-Portales J., Downs R. W., Jr, Dequeker J., Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995 Nov 30;333(22):1437–1443. doi: 10.1056/NEJM199511303332201. [DOI] [PubMed] [Google Scholar]
  19. Lukert B. P., Raisz L. G. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990 Mar 1;112(5):352–364. doi: 10.7326/0003-4819-112-5-352. [DOI] [PubMed] [Google Scholar]
  20. Magaro M., Altomonte L., Mirone L., Zoli A., Corvino G. Bone GLA protein (BGP) levels and bone turnover in rheumatoid arthritis. Br J Rheumatol. 1989 Jun;28(3):207–211. doi: 10.1093/rheumatology/28.3.207. [DOI] [PubMed] [Google Scholar]
  21. Munro R., Capell H. Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann Rheum Dis. 1997 May;56(5):326–329. doi: 10.1136/ard.56.5.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Patel S. Current and potential future drug treatments for osteoporosis. Ann Rheum Dis. 1996 Oct;55(10):700–714. doi: 10.1136/ard.55.10.700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Peel N. F., Moore D. J., Barrington N. A., Bax D. E., Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis. 1995 Oct;54(10):801–806. doi: 10.1136/ard.54.10.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Peel N. F., Spittlehouse A. J., Bax D. E., Eastell R. Bone mineral density of the hand in rheumatoid arthritis. Arthritis Rheum. 1994 Jul;37(7):983–991. doi: 10.1002/art.1780370702. [DOI] [PubMed] [Google Scholar]
  26. Raisz L. G. The osteoporosis revolution. Ann Intern Med. 1997 Mar 15;126(6):458–462. doi: 10.7326/0003-4819-126-6-199703150-00007. [DOI] [PubMed] [Google Scholar]
  27. Ross P. D., Davis J. W., Epstein R. S., Wasnich R. D. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991 Jun 1;114(11):919–923. doi: 10.7326/0003-4819-114-11-919. [DOI] [PubMed] [Google Scholar]
  28. Ross P. D. Osteoporosis. Frequency, consequences, and risk factors. Arch Intern Med. 1996 Jul 8;156(13):1399–1411. doi: 10.1001/archinte.156.13.1399. [DOI] [PubMed] [Google Scholar]
  29. van den Brink H. R., Lems W. F., van Everdingen A. A., Bijlsma J. W. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis. Ann Rheum Dis. 1993 Apr;52(4):302–305. doi: 10.1136/ard.52.4.302. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES